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Background: TomoTherapy (Accuray, USA) has an image-guided radiotherapy system with a megavoltage (MV) X-ray
source and an on-board imaging device. This system allows one to acquire the delivery sinogram during the actual
treatment, which partly includes information from the irradiated object. In this study, we try to develop image
reconstruction during treatment with helical tomotherapy.
Findings: Sinogram data were acquired during helical tomotherapy delivery using an arc-shaped detector array that
consists of 576 xenon-gas filled detector cells. In preprocessing, these were normalized with full air-scan data. A
software program was developed that reconstructs 3D images during treatment with corrections as; (1) the regions
outside the field were masked not to be added in the backprojection (a masking correction), and (2) each voxel of the
reconstructed image was divided by the number of the beamlets passing through its voxel (a ray-passing correction).
The masking correction produced a reconstructed image, however, it contained streak artifacts. The ray-passing
correction reduced this artifact. Although the SNR (the ratio of mean to standard deviation in a homogeneous region)
and the contrast of the reconstructed image were slightly improved with the ray-passing correction, use of only the
masking correction was sufficient for the visualization purpose.
Conclusions: The visualization of the treatment area was feasible by using the sinogram in helical tomotherapy. This
proposed method would be useful in the treatment verification.
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As radiotherapy is complex, treatment verification be-
comes significant. The evaluation of the absorbed dose
in phantoms is strongly recommended for all patients
having intensity-modulated radiotherapy (IMRT) [1]. In
addition, accuracy of the patient setup is more important
in the IMRT than that in the conventional radiotherapy.
Image-guided radiotherapy (IGRT) can entail correcting
the patient position just prior to treatment by gathering
information about anatomical locations during setup.
IGRT can utilize various imaging technologies such as
the portal images of the treatment beam [2-5], magnetic
resonance imaging [6], ultrasound [7,8], and computed
tomography (CT) [9,10].* Correspondence: haga-haga@umin.ac.jp
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unless otherwise stated.TomoTherapy® has an IGRT system with megavoltage
(MV) X-ray source and an on-board imaging device
[11]. With the MV CT, it became feasible to perform ef-
ficient daily-3D registration of the patient position be-
fore each treatment delivery. This system also allows one
to acquire the delivery sinogram during the actual treat-
ment. The sinogram has often been used in the treat-
ment verification [12,13], and one can come up with the
visualization of treatment area from the sinogram. For
conventional linear accelerators, in fact, CT reconstruc-
tion with portal images during rotational treatment such
as a volumetric modulated arc therapy (VMAT) has
been successfully performed [14,15]. Also the MV CT
reconstruction during treatment in helical TomoTher-
apy® delivery has been first tried in Ref. [16], where the
insertion of full field-of-view (FOV) beamlets was coop-
erated with the treatment sinogram. In this note, we
focus on the image reconstruction of treatment area
without full FOV insertion.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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CT reconstruction algorithm that includes corrections for
the heterogeneous beam profile and the geometrical
disagreement between the X-ray source position and
the detector curvature. Then, the feasibility of the re-
construction of the treatment area was examined with
the treatment sinogram to a phantom, which includes
the information of the irradiated part of the phantom.
Materials and methods
All data were obtained on a TomoTherapy® unit at
Accuray in Madison, Wisconsin. The factory IMRT test
plan was irradiated to TomoPhantom® (Accuray, USA)
with density plugs. This test plan prescribes 10 Gy for
two cylindrical targets (3 cm radius and 6 cm length)
which are seen as blue and sky-blue circles in Figure 1(a).
Sinogram data were acquired during helical TomoTher-
apy® deliveries using an arc-shaped detector array con-
sisting of 576 xenon-gas filled detector cells, of which
the data from middle 527 cells were used in the recon-
struction. The data has the following acquisition prop-
erties: gantry rotation period 14 s, data sampling rate
300 Hz, starting view angle 229.371°, and couch travel
distance over entire data sample 90.6 mm. There has 52,788
samples, and thus, the couch speed was 0.515 mm/s.
The dose distribution in the treatment planning sys-
tem (TPS) and a part of the corresponding delivery sino-
gram are shown in Figures 1(a) and (b), respectively.
The sinogram was normalized with full air-scan data to
the correct heterogeneous beam profile and modulated
beam intensity of TomoTherapy®.Figure 1 (a) Dose distribution of the factory IMRT test plan in the TomThe reconstruction was performed with an in-house
program employing the filtered back projection (FBP) al-
gorithm using Shepp-Logan filter. Because the source-to-
isocenter distance (85.0 cm) is smaller than the detector
radius of curvature (99.8 cm), our program converts the
original data in each detector cell into the virtual one with
the curvature corresponding source-to-isocenter geom-
etry. Then, the virtual data with a constant cell-to-cell
interval was created by linear interpolation.
In general, it is impossible to make a correct recon-
struction with a limited FOV using FBP [14]. As shown
in Figure 1(b), the area blocked by binary multileaf col-
limator (MLC) in the sinogram has a lower X-ray inten-
sity than that inside the FOV, so that the conventional
reconstruction scheme does not successfully visualize
the object. Instead this yields an unrealistically high-
attenuation area outside the irradiated site in the ob-
ject. For the visualization of the irradiated area, there-
fore, we employed two corrections. One was a masking
correction, which masks the area outside the FOV so as
not to include this area in the backprojection process.
For this, sinogram normalized by full air scan, Pβ̃ γð Þ
where β and γ denote the gantry and fan angles, re-
spectively, can be expressed as,
Pβ
̃
γð Þ ¼ 1 ; if Pβ γð Þ=P
air
β γð Þ < p
0
Pβ γð Þ=Pairβ γð Þ ; otherwise
(
ð1Þ
where p’ means the threshold for masking region, and
here, we employed p’ = 0.2. With this correction, theoPhantom® and (b) corresponding delivery sinogram.
Figure 2 Reconstruction images; (a) with full FOV, (b) with no masking and no ray-passing correction, (c) with masking correction only
(p’ = 0.2), (d) with both corrections and (p' = 0.2 and R(γ, β') = 0.55), (e) with both corrections with broader reconstruction and (p' = 0.2
and R(γ, β') = 0.35), and (f) the overlapped image between (a) and (e). The image (a) was reconstructed with 4 mm/rotation, whereas the
others were reconstructed with 7.2 mm/rotation which can depend on the treatment plan.
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masking region is discontinuous. Of course, this is not
true, but it enhances the information from the irradiated
area in the FBP reconstruction scheme.
The other correction was a ray-passing adjustment,
which normalized each voxel of the reconstructed image
to the number of the X-rays passing through the corre-
sponding voxel. Namely, using the masking function,
M γ; βð Þ ¼ 1 ; if p
0





the correction factor for ray-passing can be expressed
as,
R γ; β
0  ¼ Θ
Z 2π
0




M γ; βð Þdβ
: ð3Þ
The backprojection generates stronger signals from
the angles passing more X-rays. The ray-passing correc-
tion corrects this effect. The reconstructed region wasTable 1 Results of contrast, homogeneity, and SNR analyses
Reconstruction Contrast Homogeneity
Full FOV 6.17 0.99-1.02
Masking only 1.79 0.83-1.15
Full corrections 1.89 0.91-1.06
The contrast was evaluated by the ratio of the mean value of regions A, C, and D to
values of the mean value in the regions A, C, and D.controlled by β’ in Eq. (3). In this study, the area irradi-
ated with more than 35% (R(γ, β’) = 0.35) and 55% (R
(γ, β’) = 0.55) of the maximum was reconstructed and the
other area was masked.
The contrast in the images was evaluated by the ratio
of the signal in high-density regions to that in low-
density regions in the object. The homogeneity was eval-
uated from the three regions that are composed of the
same material. The signal-to-noise ratio (SNR) inside the
region-of-interest (ROI) was also evaluated.
Results and discussion
Figures 2(a)-(f) show the reconstructed images using a full
FOV, with no masking and no ray-passing corrections,
with masking correction only, and with both corrections,
respectively. Without masking and ray-passing corrections
(Figure 2(b)), the visualization of the treatment area was
poor. Use of the masking correction and the ray-passing
correction improved the reconstructed image for the
treatment site (Figures 2(c)-(e)). The masking correction
made the image clearly visible, however, a streak artifact
was introduced (Figure 2(c)). The ray-passing correction
reduced this artifact (Figures 2(d) and (e)). In Figure 2(f),
the image difference between Figures 2(a) and (e) isSNR @ A SNR @ B SNR @ C SNR @ D
19.61 2.98 16.97 19.91
18.13 16.28 9.33 55.50
20.47 16.70 10.53 44.44
that of region B in Figure 3. The homogeneity was evaluated by the min-max
Figure 3 Enlarged displays of the reconstruction images with full FOV (left panel), with masking correction only (middle panel), and with
both corrections (right panel).
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plugs were well reproduced in Figure 2(f). On the other
hand, the difference can depend on the density plug, be-
cause of the low contrast of Figure 2(e) in comparison
with Figure 2(a).
Table 1 shows the quantitative evaluation of contrast,
homogeneity, and SNR. The contrast index was calculated
by the ratio of the mean value of regions A, C, and D to
that of region B (see Figure 3). As expected, the contrast
for the in-treatment images is considerably poorer than
for the full FOV image. The homogeneity, as evaluated by
the min-max values of the mean value in the regions A, C,
and D has the same tendency. On the other hand, the
SNR can be enhanced in the in-treatment images, pre-
sumably, due to the blurring effect.
In the analysis of image contrast and homogeneity,
the ray-passing correction improved the image quality,
but no dramatic change in visibility was yielded. Of
course, this is not a general conclusion. One set of ques-
tions might be to further examine how well this type of
technique works for different cases, such as different tar-
get sizes, different anatomical regions, and with different
levels of leaf modulation.
Although a further study will be required, the present
result encouraged us to develop the record-and-verify
system with the reconstructed delivery area from the ac-
tual treatment. Although a further study will be re-
quired, the present result encouraged us to develop the
record-and-verify system with the reconstructed delivery
area from the actual treatment. Also one may be inter-
ested in the dose reconstruction using present method.
The present method cannot be applied for the dose re-
construction directly. However, the dose reconstruction
in each treatment session requires the information of
the patient location during treatment, which can be pro-
vided by the present method. Thus, the development of
the image reconstruction using the delivery sinogram
would be a promising tool for in-vivo dosimetry as well
as for verification of irradiated areas.Conclusion
A reconstruction technique using the treatment sino-
gram has been developed for helical Tomotherapy. The
improved visibility of structures in the reconstructed
image makes this a promising tool for verifying relative
anatomical positions during the course of a treatment.
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